Search Results 611-620 of 17376 for soluble fiber
The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.
Participation eligibility · Recent (< 1 month) hospitalization for heart failure · Ongoing requirement for PDE5 inhibitor, organic nitrate or soluble guanylyl ...
The purpose of this study is to determine if the set-point for fasting insulin secretion, and the subsequent response to hyperglycemia, is altered in people ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...
The purpose of this study is to determine the effect of GLP-1 in priming β-cells for insulin secretion. Participation eligibility. Participant eligibility ...
About this study. Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic ...
This 8-week randomized, open-label evaluation will examine the acute safety and tolerability of 4 different dosing regimens of Acthar to inform dose selection ...
About this study. The goal of this study is to collect tissue for a research project in which tendinopathy is induced in immunocompromised rats.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!